In the mad scramble to find safe and effective drugs to treat patients suffering from COVID-19, the winners and losers amongst the litany of candidates are starting to emerge, with a previously-strong contender—hydroxychloroquine—falling from favor with the FDA, and another commonly-used drug seeing success in a major clinical trial. Theread more
One of the few reassuring aspects of the effects of COVID-19 has been that it has a markedly mild effect on young children, with the majority of young ones that contract the disease developing only mild symptoms. But an alarming trend is being reported by medical professionals in the UKread more
In the race to provide effective treatments for patients stricken with COVID-19, hydroxychloroquine—an already available, albeit now controversial, drug—is considered to be amongst the front-running candidates in the fight against the coronavirus that’s behind the pandemic. But despite promising in vitro study results (and a premature endorsement by President Donaldread more
A key tool in the fight against the COVID-19 pandemic that is currently holding the world hostage is a vaccine that would impart immunity against an infection caused by the SARS-CoV-2 virus, and the widespread distribution of such an agent may be necessary before the world can start getting backread more